Versatope Therapeutics

0 followers


Versatope Therapeutics is an infectious disease company with two lead development programs and others at the preclinical stage. Versatope delivers immunity by customizing nano-size vesicles by using synthetic biology for biopharmaceutical applications.

Industries

Employees

11-50

Links

Org chart

Christopher Locher
CEO & Co-Founder

Christopher Locher

Collapse
Kumkum Saxena
VP, Microbiology & Process Development
Alexandra Conceicao
Project Manager
Erin Neff
Project and Alliance Manager
Francisco Santos
Business Development Manager
Matt DeLisa
Co-Founder